Explore these archived CLC webinars which are free to College members. They cover a wide range of topics – 

  • Biomarkers in Asthma Management - T. Mahr, MD, FACAAI; J. Darveaux, MD; Understand the “soup” of all these different biomarkers, and how they impact our clinical practice. (10/10/2017)
  • Diagnosing and Living with COPD - G. Stevens, MD; The Allergy and Asthma Network presents this webinar on the common, preventable and treatable disease of Chronic Obstructive Pulmonary Disease (05/23/2019)
  • House Dust Mite Allergy - E. Meltzer, MD, FACAAI; J. Oppenheimer, MD, FACAAI; M. Blaiss, MD, FACAAI; This webinar reviews the latest published data on house dust mite management and break many of the myths of “what works best” for our patients. (05/13/2019)
  • How to be an Advocate for Allergists - S. Imbeau, MD, FACAAI; J. Seyerle, MD, FACAAI; This webinar will address how allergists can impact issues important to the future of allergy by advocating at the local, state and federal level. (12/07/2016)
  • Managing Atopic Dermatitis Patients with a Yardstick - M. Boguniewicz, MD, FACAAI; L. Fonacier, MD, FACAAI; The Atopic Dermatitis Yardstick is part of a series developed in response to the need to proactively address the loss of disease control for atopic illnesses at all levels of severity. (08/29/2018)
  • Oral Food Challenge: A Primer for the Practitioner - J. Spergel, MD, PhD; D. Fleischer, MD; M. Greenhawt, MD, MBA, MSc. This recorded webinar provides a deep dive on how to safely perform Oral Food Challenges in your office. (04/16/2019)
  • Step Up Care for Childhood Asthma - The Pediatric Asthma Yardstick - B. Chipps, MD, FACAAI; L. Bacharier, MD, FACAAI; The Pediatric Asthma Yardstick provides an in-depth assessment of when and how to step-up therapy for children with poorly-controlled asthma. (02/28/2019)
  • Uncontrolled Asthma: The Role of Type 2 Inflammation - J. Bernstein, MD, FACAAI; J. Bayuk, DO, FACAAI; This webinar will discuss asthma heterogeneity and pathobiology, the role of type 2 cytokines, phenotypes and endotypes, type 2 inflammation and comorbidities and management and biologics. (06/12/2019)